Who to call at Pliant Therapeutics, Inc., and when
Fundz watches for the moments Pliant Therapeutics, Inc. starts buying, and tells you who to reach.
- An alert the day Pliant Therapeutics, Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Pliant Therapeutics, Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Pliant Therapeutics, Inc.. With Fundz connected, it knows.
Pliant Therapeutics, Inc.
A senior executive or director joined, left, or changed roles. An 8-K is the notice a US public company must file within four business days of a major event.
pliantrx.comLeadership shakeup: 3 executive changes at Pliant Therapeutics in the last 90 days. Clusters like this usually mean more senior seats open over the next few months.
See every company with multiple executive changes →AI Executive Summary
AI-powered analysis of 8-K filing content
Pliant Therapeutics accepted the resignation of Chief Business Officer Hans Hull, effective October 20, 2025. The company states the departure was not due to any disagreement over its operations, policies, or practices.
Key Takeaways
Chief Business Officer Hans Hull resigned effective October 20, 2025, and the company accepted the resignation the same day.
The filing states the resignation was not due to a disagreement on any matter related to the company's operations, policies, or practices.
2 more takeaways
Related Filings (8)
8 more filings from Pliant Therapeutics, Inc. in the last 90 days
Filing Overview
What This Means
Pliant Therapeutics, Inc. filed with the SEC. Fundz turns 8-K material events into an alert with the right executive attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
4 screens from a live account. No signup.